List of SBIR/STTR awards granted to Forcyte Biotechnologies
Forcyte BiotechnologiesName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Forcyte Biotechnologies in August, 2018 for $224,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD097002-01 | Phase I | 224,997 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Forcyte Biotechnologies in August, 2019 for $826,810.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR002350-02 | Phase II | 826,810 | August 6, 2019 | |||||||
A SBIR Phase I contract was awarded to Forcyte Biotechnologies in April, 2018 for $288,031.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AT009962-01 | Phase I | 288,031 | April 5, 2018 | |||||||
A SBIR Phase I contract was awarded to Forcyte Biotechnologies in January, 2018 for $224,987.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR002350-01 | Phase I | 224,987 | January 1, 2018 | |||||||
A STTR Phase I contract was awarded to Forcyte Biotechnologies in September, 2021 for $350,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41GM146269-01 | Phase I | 350,000 | September 14, 2021 | |||||||
A SBIR Phase I contract was awarded to Forcyte Biotechnologies in July, 2021 for $352,511.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK129187-01A1 | Phase I | 352,511 | July 1, 2021 | |||||||
